The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast

Background: Reprogrammed cell therapy has not been applied for clinical purposes due to the malignancy issue. The aim of this study was to design the recombinant vector of the transcription factors and analyze the effectiveness of cell-penetrating peptide delivering system for human primary fibrobla...

Full description

Bibliographic Details
Main Authors: Melinda Remelia, Budiman Bela, Silvia Tri Widyaningtyas, Radiana Dhewayani Antarianto, Nuzli Fahdia Mazfufah, Jeanne Adiwinata Pawitan
Format: Article
Language:English
Published: Cell and BioPharmaceutical Institute 2023-03-01
Series:MCBS (Molecular and Cellular Biomedical Sciences)
Online Access:https://cellbiopharm.com/ojs/index.php/MCBS/article/view/279
_version_ 1797858612858585088
author Melinda Remelia
Budiman Bela
Silvia Tri Widyaningtyas
Radiana Dhewayani Antarianto
Nuzli Fahdia Mazfufah
Jeanne Adiwinata Pawitan
author_facet Melinda Remelia
Budiman Bela
Silvia Tri Widyaningtyas
Radiana Dhewayani Antarianto
Nuzli Fahdia Mazfufah
Jeanne Adiwinata Pawitan
author_sort Melinda Remelia
collection DOAJ
description Background: Reprogrammed cell therapy has not been applied for clinical purposes due to the malignancy issue. The aim of this study was to design the recombinant vector of the transcription factors and analyze the effectiveness of cell-penetrating peptide delivering system for human primary fibroblast transfection to avoid the malignancy issue. Materials and methods: The constructions of CCAT/enhancer binding protein alpha (CEBPA), hepatocyte nuclear factor 4 alpha (HNF4A), nuclear receptor subfamily 1 group I member 2 (NR1I2) were confirmed with DNA digestion and sequencing. Breast reduction (BRED) and palate (PAL) tissue were used as human primary fibroblast sources. The transcription factors were delivered into BRED and PAL with recombination of avian leukosis sarcoma virus (ALSV), human immunodeficiency virus (HIV) matrix, and regulator of expression of virion proteins (Rev) (ALMR), tagged with enhanced green fluorescence protein (eGFP). Post-transfection cells were then cultivated with optimized medium. Gene expression was measured with quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Results: Gene expression levels of CEBPA, HNF4A, NR1I2, glutamate-ammonia ligase (GLUL), albumin (ALB), and cytochrome P450 (CYP) were increased. Transfection with ALMR, which were more efficient in BRED than PAL fibroblasts may have the advantage in autologous cell therapy for elderly patients. Conclusion: Transfection of transcription factors to human primary fibroblast may be performed by using constructions of plasmid as designed in this study. Keywords: recombinant plasmid, hepatocyte-like cells, primary fibroblasts, recombinant peptide, cell reprogramming, autologous cells therapy
first_indexed 2024-04-09T21:16:09Z
format Article
id doaj.art-465fd28537a14e35ac6281b30a1a0b0b
institution Directory Open Access Journal
issn 2527-4384
2527-3442
language English
last_indexed 2024-04-09T21:16:09Z
publishDate 2023-03-01
publisher Cell and BioPharmaceutical Institute
record_format Article
series MCBS (Molecular and Cellular Biomedical Sciences)
spelling doaj.art-465fd28537a14e35ac6281b30a1a0b0b2023-03-28T07:46:24ZengCell and BioPharmaceutical InstituteMCBS (Molecular and Cellular Biomedical Sciences)2527-43842527-34422023-03-0171283710.21705/mcbs.v7i1.279105The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human FibroblastMelinda Remelia0Budiman Bela1Silvia Tri Widyaningtyas2Radiana Dhewayani Antarianto3Nuzli Fahdia Mazfufah4Jeanne Adiwinata Pawitan5Department of Histology, Faculty of Medicine, Universitas Kristen Indonesia, JakartaDoctoral Program, Biomedical Science, Faculty of Medicine, Universitas Indonesia, JakartaVirology and Cancer Pathobiology Research Center, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National Central General Hospital, JakartaDoctoral Program, Biomedical Science, Faculty of Medicine, Universitas Indonesia, JakartaStem Cell Research and Tissue Engineering - Indonesia Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, JakartaDoctoral Program, Biomedical Science, Faculty of Medicine, Universitas Indonesia, JakartaBackground: Reprogrammed cell therapy has not been applied for clinical purposes due to the malignancy issue. The aim of this study was to design the recombinant vector of the transcription factors and analyze the effectiveness of cell-penetrating peptide delivering system for human primary fibroblast transfection to avoid the malignancy issue. Materials and methods: The constructions of CCAT/enhancer binding protein alpha (CEBPA), hepatocyte nuclear factor 4 alpha (HNF4A), nuclear receptor subfamily 1 group I member 2 (NR1I2) were confirmed with DNA digestion and sequencing. Breast reduction (BRED) and palate (PAL) tissue were used as human primary fibroblast sources. The transcription factors were delivered into BRED and PAL with recombination of avian leukosis sarcoma virus (ALSV), human immunodeficiency virus (HIV) matrix, and regulator of expression of virion proteins (Rev) (ALMR), tagged with enhanced green fluorescence protein (eGFP). Post-transfection cells were then cultivated with optimized medium. Gene expression was measured with quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Results: Gene expression levels of CEBPA, HNF4A, NR1I2, glutamate-ammonia ligase (GLUL), albumin (ALB), and cytochrome P450 (CYP) were increased. Transfection with ALMR, which were more efficient in BRED than PAL fibroblasts may have the advantage in autologous cell therapy for elderly patients. Conclusion: Transfection of transcription factors to human primary fibroblast may be performed by using constructions of plasmid as designed in this study. Keywords: recombinant plasmid, hepatocyte-like cells, primary fibroblasts, recombinant peptide, cell reprogramming, autologous cells therapyhttps://cellbiopharm.com/ojs/index.php/MCBS/article/view/279
spellingShingle Melinda Remelia
Budiman Bela
Silvia Tri Widyaningtyas
Radiana Dhewayani Antarianto
Nuzli Fahdia Mazfufah
Jeanne Adiwinata Pawitan
The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
MCBS (Molecular and Cellular Biomedical Sciences)
title The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
title_full The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
title_fullStr The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
title_full_unstemmed The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
title_short The Use of Cell-penetrating Peptide for Delivery of Recombinant Transcription Factor DNA into Primary Human Fibroblast
title_sort use of cell penetrating peptide for delivery of recombinant transcription factor dna into primary human fibroblast
url https://cellbiopharm.com/ojs/index.php/MCBS/article/view/279
work_keys_str_mv AT melindaremelia theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT budimanbela theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT silviatriwidyaningtyas theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT radianadhewayaniantarianto theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT nuzlifahdiamazfufah theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT jeanneadiwinatapawitan theuseofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT melindaremelia useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT budimanbela useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT silviatriwidyaningtyas useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT radianadhewayaniantarianto useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT nuzlifahdiamazfufah useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast
AT jeanneadiwinatapawitan useofcellpenetratingpeptidefordeliveryofrecombinanttranscriptionfactordnaintoprimaryhumanfibroblast